900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Thymoma, type B1	Thymoma, type B1, malignant
Thymoma, type B2	Thymoma, type B2, malignant
Thymoma, type B3	Thymoma, type B3, malignant
Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial	Product containing only thymalfasin (medicinal product)
Thymosin alpha 1 1.6mg powder for injection solution vial + diluent	Product containing only thymalfasin (medicinal product)
Thymoxamine 0.5% conventional release eye drops	Product containing only moxisylyte in ocular dose form (medicinal product form)
Thymoxamine 0.5% preservative-free eye drops	Product containing only moxisylyte in ocular dose form (medicinal product form)
Thyroid TNM finding	American Joint Committee on Cancer allowable value
Thyroid disease monitoring NOS	Thyroid disease monitoring
Thyroid disease monitoring NOS	Thyroid disease monitoring
Thyroid eye disease with exophthalmos	Exophthalmos due to thyroid eye disease (disorder)
Thyroid eye disease with strabismus	Exophthalmos due to thyroid eye disease (disorder)
Thyroid gland excision	Thyroidectomy
Thyroid incision NOS	Incision of thyroid
Thyroid incision NOS	Incision of thyroid
Thyroid related antibody	Thyroid antibody
Thyroiditis NOS	Thyroiditis
Thyroiditis NOS	Thyroiditis
Thyrotoxicosis NOS	Thyrotoxicosis
Thyrotoxicosis NOS	Thyrotoxicosis
Thyrotropin alfa 0.9mg/mL powder for injection solution vial	Thyrotrophin only product
Thyrotropin alfa 1.1mg/vial powder	Thyrotrophin only product
Thyroxine sodium 100micrograms tablet	Levothyroxine sodium anhydrous 100 microgram oral tablet
Thyroxine sodium 25micrograms tablet	Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)
Thyroxine sodium 50micrograms tablet	Levothyroxine sodium anhydrous 50 microgram oral tablet
Tibia X-ray	Plain X-ray of tibia
Tic disorder unspecified	Tic (finding)
Tic disorder unspecified	Tic (finding)
Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial	Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 1g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 20g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 3g powder for injection solution vial	Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Tiludronate disodium	Product containing tiludronic acid (medicinal product)
Time since symptom started NOS	Symptom findings in relation to start time (finding)
Time since symptom started NOS	Symptom findings in relation to start time (finding)
Time symptom lasts NOS	Symptom findings in relation to time lasts
Time symptom lasts NOS	Time symptom lasts
Time zone syndrome	Jet lag (finding)
Timed unsupported steady stand test	Timed unsupported steady stand time
Timolol maleate 0.25% ophthalmic solution	Timolol (as timolol maleate) 2.5 mg/mL eye drops
Timolol maleate 0.5%	Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate 0.5% ophthalmic solution	Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate+bendroflumethiazide	Product containing bendroflumethiazide and timolol (medicinal product)
Tinnitus symptom NOS	Tinnitus
Tinnitus symptom NOS	Tinnitus
Tiotropium 18microgram inhalation powder capsule	Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tiotropium 18microgram inhalation powder capsule with device	Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tis (0): Carcinoma in situ (limited to fallopian tube mucosa)	American Joint Committee on Cancer cTis (qualifier value)
Tis (0): Carcinoma in situ (vagina)	American Joint Committee on Cancer cTis (qualifier value)
Tis category	American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ ("flat tumor" of urinary bladder)	American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ (endometrium/uterine cervix)	American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ	American Joint Committee on Cancer cTis (qualifier value)
Tis: Epithelium only (carcinoma in situ, no invasion)	American Joint Committee on Cancer cTis (qualifier value)
Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis)	American Joint Committee on Cancer cTis (qualifier value)
Tis: Tumor invades lamina propria (gastrointestinal tumor)	American Joint Committee on Cancer cTis(LAMN) (qualifier value)
Tis: Tumor invades muscularis mucosae (colon/rectum)	American Joint Committee on Cancer cTis (qualifier value)
Tissue culture for chromosome analysis, more complex procedure with special extra counts	Chromosome analysis
Tissue cytology NOS	Cytologic test
Tissue cytology NOS	Cytologic test
Tissue disruption operation NOS	Tissue disruption operation
Tissue disruption operation NOS	Tissue disruption operation
Tissue injection for local action	Administration using positive pressure and a needle or other equipment to drive a substance into the body.
Tissue injection for local action NOS	Administration using positive pressure and a needle or other equipment to drive a substance into the body.
Tissue injection for local action NOS	Administration using positive pressure and a needle or other equipment to drive a substance into the body.
Tissue kallikrein	Kininogen
Tissue processing technique, complex, embed, cut and stain, per autopsy	Tissue processing technique
Tissue processing technique, complex, embed, cut and stain, per surgical specimen	Tissue processing technique
Titanium dioxide 20% paste	Product containing only titanium dioxide (medicinal product)
Tobacco consumption NOS	Tobacco use and exposure
Tobacco consumption NOS	Tobacco use and exposure
Tobacco dependence with current use	Tobacco dependence syndrome
Tobacco processor NOS	Tobacco processor
Tobacco processor NOS	Tobacco processor
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension	Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)
Tobramycin 1.2g powder for injection solution vial	Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial
Tobramycin 1.2mg/mL injection	Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial
Tobramycin 300mg/5mL nebulizer solution	Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug)
Tobramycin 60mg/mL solution	Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug)
Tocilizumab 20mg/mL conventional release solution for injection	Tocilizumab only product in parenteral dose form
Tocilizumab 20mg/mL solution for intravenous infusion	Tocilizumab only product in parenteral dose form
Tocopherol	Vitamin E and/or vitamin E derivative (substance)
Toe X-ray	Plain X-ray of toe (procedure)
Toe X-ray	Plain X-ray of toe (procedure)
Toe X-ray	Plain X-ray of toe (procedure)
Toe flap	Flap (substance)
Tolnaftate+chlorhexidine hydrochloride	Product containing chlorhexidine and tolnaftate (medicinal product)
Tolterodine 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine L-tartrate 4mg prolonged-release oral capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 2mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 2mg prolonged-release oral capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Tolterodine tartrate 4mg m/r capsule	Product containing only tolterodine in oral dose form (medicinal product form)
Toluene diisocyanate specific extract	Toluene-2-4-diisocyanate
Tomato - dietary	Tomato (substance)
Tomilol	Timolol (substance)
Tomography - NOS	Tomographic imaging procedure (procedure)
Tomography - NOS	Tomographic imaging procedure (procedure)
Tongue diseases NOS	Disorder of tongue (disorder)
Tongue diseases NOS	Disorder of tongue (disorder)

Start Previous Page 211 of 235 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)